A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.

Clinical trial NCT04515290 · COMPLETED

Trial details

NCT number: NCT04515290
Sponsor: Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Heart Failure

Start date: 2020-05-07
Primary completion: 2022-04-22
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.